Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Int J Mol Sci ; 25(4)2024 Feb 16.
Article in English | MEDLINE | ID: mdl-38397015

ABSTRACT

Diabetes mellitus (DM) is a highly prevalent disease worldwide, estimated to affect 1 in every 11 adults; among them, 90-95% of cases are type 2 diabetes mellitus. This is partly attributed to the surge in the prevalence of obesity, which has reached epidemic proportions since 2008. In these patients, cardiovascular (CV) risk stands as the primary cause of morbidity and mortality, placing a substantial burden on healthcare systems due to the potential for macrovascular and microvascular complications. In this context, leptin, an adipocyte-derived hormone, plays a fundamental role. This hormone is essential for regulating the cellular metabolism and energy balance, controlling inflammatory responses, and maintaining CV system homeostasis. Thus, leptin resistance not only contributes to weight gain but may also lead to increased cardiac inflammation, greater fibrosis, hypertension, and impairment of the cardiac metabolism. Understanding the relationship between leptin resistance and CV risk in obese individuals with type 2 DM (T2DM) could improve the management and prevention of this complication. Therefore, in this narrative review, we will discuss the evidence linking leptin with the presence, severity, and/or prognosis of obesity and T2DM regarding CV disease, aiming to shed light on the potential implications for better management and preventive strategies.


Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Leptin , Obesity , Adult , Humans , Cardiovascular Diseases/metabolism , Diabetes Mellitus, Type 2/metabolism , Leptin/metabolism , Obesity/metabolism
2.
Nutrients ; 13(11)2021 Nov 19.
Article in English | MEDLINE | ID: mdl-34836405

ABSTRACT

Cardiovascular disease (CVD) is the most common cause of morbidity and mortality in developed countries. The prevalence of CVD is much higher in patients with type 2 diabetes mellitus (T2DM), who may benefit from lifestyle changes, which include adapted diets. In this review, we provide the role of different groups of nutrients in patients with T2DM and CVD, as well as dietary approaches that have been associated with better and worse outcomes in those patients. Many different diets and supplements have proved to be beneficial in T2DM and CVD, but further studies, guidelines, and dietary recommendations are particularly required for patients with both diseases.


Subject(s)
Cardiovascular Diseases/diet therapy , Diabetes Mellitus, Type 2/diet therapy , Diabetic Cardiomyopathies/diet therapy , Diet/methods , Nutrition Therapy/methods , Cardiovascular Diseases/complications , Diabetes Mellitus, Type 2/complications , Diabetic Cardiomyopathies/complications , Dietary Supplements , Humans , Nutrients/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...